Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 10,000 shares at $478.46 ($4.8M) on 2015-03-24, disclosed to the SEC on 2015-03-25.
Scheduled sale ($4.8M) by SVP Strategy Investor Relation under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $476.50 | 5,157 | $2.5M | 51.4% |
| 2 | $474.79 | 300 | $142K | 3.0% |
| 3 | $475.83 | 200 | $95K | 2.0% |
| 4 | $476.53 | 740 | $353K | 7.4% |
| 5 | $477.59 | 573 | $274K | 5.7% |
| 6 | $478.46 | 530 |
| $254K |
| 5.3% |
| 7 | $479.39 | 500 | $240K | 5.0% |
| 8 | $480.70 | 800 | $385K | 8.1% |
| 9 | $481.59 | 1,100 | $530K | 11.1% |
| 10 | $482.56 | 100 | $48K | 1.0% |
| Total | $477.70 avg | 10,000 | $4.8M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |
| REGN | SELL | 2014-08-19 | $1.3M | — | Filing → |